Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$67.72 USD
-0.14 (-0.21%)
Updated May 17, 2024 04:00 PM ET
5-Strong Sell of 5 5
B Value C Growth C Momentum C VGM
Brokerage Reports
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 301 - 320 ( 523 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 3
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Jan 27
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Jan 20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Prop. 61: What if Federal and State Agencies Get VAs Price? - Buy
Provider: G.RESEARCH, LLC
Analyst: HE J
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Introducing Our NASH Splash Report: Themes From Our Recent KOL Panel
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E